Skip to main content
SpringerLink
Log in

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

  • Review
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

This review of angiogenesis aims to describe (a) stimuli that either elicit or antagonize angiogenesis, (b) the response of the vasculature to angiogenic or antiangiogenic stimuli, i.e., processes required for the formation of new vessels, (c) aspects of angiogenesis relating to tissue remodeling and disease, and (d) the potential of angiogenic or antiangiogenic therapeutic measures. Angiogenesis, the formation of new vessels from existing microvessels, is important in embryogenesis, wound healing, diabetic retinopathy, tumor growth, and other diseases. Hypoxia and other as yet ill-defined stimuli drive tumor, inflammatory, and connective tissue cells to generate angiogenic molecules such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), and others. Natural and synthetic angiogenesis inhibitors such as angiostatin and thalidomide can repress angiogenesis. Angiogenic and antiangiogenic molecules control the formation of new vessels via different mechanisms. VEGF and FGF elicit their effects mainly via direct action on relevant endothelial cells. TGF-β and PDGF can attract inflammatory or connective tissue cells which in turn control angiogenesis. Additionally, PDGF may act differently on specific phenotypes of endothelial cells that are engaged in angiogenesis or that are of microvascular origin. Thus phenotypic traits of endothelial cells committed to angiogenesis may determine their cellular responses to given stimuli. Processes necessary for new vessel formation and regulated by angiogenic/antiangiogenic molecules include the migration and proliferation of endothelial cells from the microvasculature, the controlled expression of proteolytic enzymes, the breakdown and reassembly of extracellular matrix, and the morphogenic process of endothelial tube formation. In animal models some angiogenesis-dependent diseases can be controlled via induction or inhibition of new vessel formation. Lifethreatening infantile hemangiomas are a first established indication for antiangiogenic therapy in humans. Treatment of other diseases by modulation of angiogenesis are currently tested in clinical trials. Thus the manipulation of new vessel formation in angiogenesis-dependent conditions such as wound healing, inflammatory diseases, ischemic heart and peripheral vascular disease, myocardial infarction, diabetic retinopathy, and cancer is likely to create new therapeutic options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

VEGF :

Vascular endothelial growth factor

FGF :

Fibroblast growth factor

TGF :

Transforming growth factor

PDGF :

Platelet-derived growth factor

CAM :

Chorionic allantoic membrane assay

References

  1. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT (1994) Elevated vascular permeability factor/vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450

    Google Scholar 

  2. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases. N Engl J Med 331:1480–1487

    Article  CAS  PubMed  Google Scholar 

  3. Anagnostou Z, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974–3978

    Google Scholar 

  4. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA (1989) An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544–4548

    Google Scholar 

  5. Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during angiogenesis. Microvasc Res 14:53–65

    Google Scholar 

  6. Baird A, Böhlen P (1990) Fibroblast growth factors. In; Sporn MB Roberts AB (eds) Peptide growth factors and their receptors I. Springer, Berlin Heidelberg New York, pp 369–418

    Google Scholar 

  7. Bar RS, Boes M, Booth BA, Dake BL, Henley S, Hart MN (1989) The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 124:1841–1848

    Google Scholar 

  8. Barger CA, Beeuwkes R, Lainley L, Silverman KJ (1984) Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 310:175–177

    Google Scholar 

  9. Barnhill RL, Levy MA (1993) Regressing thin cutaneous malignant melanomas (< or =1.0 mm) are associated with angiogenesis. Am J Pathol 143:99–104

    Google Scholar 

  10. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R (1990) TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515–524

    Article  CAS  PubMed  Google Scholar 

  11. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M (1994) PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF β-receptors. J Cell Biol 125:917–928

    Google Scholar 

  12. Battler A, Scheinowitz AM, Bor A, Hasdai D, Vered Z, DiSegni E, Varda-Bloom N, Nass D, Engelberg S, Eldar M, et al (1993) Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 22:2001–2006

    Google Scholar 

  13. Beekhuizen H, Corsel-van Tilburg AJ, van Furth R (1990) Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J of Immunol 145:510–518

    Google Scholar 

  14. Beitz JG, Kim IS, Calabresi P, Frackelton ARJ (1991) Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 88:2021–2025

    Google Scholar 

  15. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield E (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153–159

    Google Scholar 

  16. Bicknell R (1994) Vascular targeting and the inhibition of angiogenesis. Ann Oncol 5 [Suppl] 4:45–50

    Google Scholar 

  17. Blei F, Wilson EL, Mignatti P, Rifkin DB (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155:568–578

    Google Scholar 

  18. Breier G, Albrecht U, Sterrer S, Risau W (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521–532

    Google Scholar 

  19. Brindle NPJ (1993) Growth factors in endothelial regeneration. Cardiovasc Res 27:1162–1172

    Google Scholar 

  20. Broadley KN, Aquino AM, Hicks B, Ditesheim JA, McGee GS, Demetriou AA, Woodward SC, Davidson JM (1989) The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor. Biotechnol Ther 1:55–68

    Google Scholar 

  21. Brogi E, Wu T, Namiki A, Isner JM (1994) Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649–652

    Google Scholar 

  22. Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569–571

    Google Scholar 

  23. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA (1994) Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157–1164

    Article  CAS  PubMed  Google Scholar 

  24. Brown RL, Breeden MP, Greenhalgh DG (1994) PDGF and TGF-β act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res 56:562–570

    Google Scholar 

  25. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio P (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629–641

    Google Scholar 

  26. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419–424

    Google Scholar 

  27. Chen HH, Chien CH, Liu HM (1994) Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 25:1651–1657

    Google Scholar 

  28. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK (1993) Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 91:977–985

    Google Scholar 

  29. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292–1296

    Article  Google Scholar 

  30. Craft PS, Harris AL (1994) Clinical prognostic significance of tumour angiogenesis. Ann Oncol 5:305–311

    Google Scholar 

  31. D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082–4085

    PubMed  Google Scholar 

  32. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582–1584

    Google Scholar 

  33. Denijn M, Ruiter DJ (1993) The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects. Melanoma Res 3:5–14

    Google Scholar 

  34. DiPietro LA, Polverini PJ (1993) Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am J Pathol 143:678–684

    Google Scholar 

  35. DiPietro LA, Nebgen DR, Polverini PJ (1994) Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res 31:178–185

    Google Scholar 

  36. Dissen GA, Lara HE, Fahrenbach WH, Costa ME, Ojeda SR (1994) Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology 134:1146–1154

    Google Scholar 

  37. Dupuy E, Bikfalvi A, Rendu F, Levy-Toledano S, Tobelem G (1989) Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels. Exp Cell Res 185:363–372

    Google Scholar 

  38. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC (1994) Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature 371:674–680

    Article  CAS  PubMed  Google Scholar 

  39. Ensoli B, Markham P, Kao V, Barillari G, Fiorelli V, Gendelman R, Raffeld M, Zon G, Gallo R (1994) Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J Clin Invest 94:1736–1746

    Google Scholar 

  40. Ezekowitz RA, Mulliken JB, Folkman J (1992) Interferon-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456–1463

    Google Scholar 

  41. Fava RA, Olsen NJ, Spencer Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341–346

    Google Scholar 

  42. Ferrara N, Winer J, Henzel WJ (1992) Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 89:698–702

    Google Scholar 

  43. Fisher JW, Nakashima J (1992) Kidney regulation of erythropoietin production. In Biochemical pharmacology of blood and bloodforming organs. Fisher JW (ed) Springer, Berlin Heidelberg New York, pp 33–48

    Google Scholar 

  44. Folkman J (1985) Toward an understanding of angiogenesis: search and discovery. Persp Biol Med 29:10–36

    Google Scholar 

  45. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27–31

    Google Scholar 

  46. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–10934

    CAS  PubMed  Google Scholar 

  47. Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M, Westermark B (1993) Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA 90:393–397

    Google Scholar 

  48. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237–239

    Google Scholar 

  49. Frank RM (1994) Vascular endothelial growth factor-its role in retinal vascular proliferation. N Engl J Med 331:1519–1520

    Google Scholar 

  50. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493–2503

    Google Scholar 

  51. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F (1994) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454–466

    Google Scholar 

  52. Goldberg MA, Schneider TJ (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269:4355–4359

    Google Scholar 

  53. Graham CA, Rivers J, Kerbel RS, Stankiewicz KS, White WL (1994) Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 145:510–514

    Google Scholar 

  54. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937–1941

    Google Scholar 

  55. Grant MB, Caballero S, Millard WJ (1993) Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization. Regul Pept 48:267–278

    Google Scholar 

  56. Grant MB, Mames RN, Fitzgerald C, Ellis EA, Aboufriekha M, Guy J (1993) Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia 36:282–291

    Google Scholar 

  57. Gupta SK, Singh JP (1994) Inhibition of endothelial cell proiferation by platelet factor-4 involves a unique action on S phase progression. J Cell Biol 127:1121–1127

    Google Scholar 

  58. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94:623–630

    Google Scholar 

  59. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y (1994) Angiogenic activity of enzymes (letter). Nature 368:198

    Google Scholar 

  60. Heimark RL, Twardzik DR, Schwartz SM (1986) Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233:1078–1080

    Google Scholar 

  61. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213–3219

    CAS  PubMed  Google Scholar 

  62. Holmgren L, Glaser A, Pfeifer-Ohlsson S, Ohlsson R (1991) Angiogenesis during human extraembryonic development in 2 volves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 113:749–754

    Google Scholar 

  63. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120–1124

    Google Scholar 

  64. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y (1991) Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51:6180–6184

    Google Scholar 

  65. Hull MA, Cullen DJE, Hawkey CJ (1994) Basic fibroblast growth factor in gastric ulceration: mucosal levels and therapeutic potential. Gastroenterology 106:A97

    Google Scholar 

  66. Ingber D (1991) Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem 47:236–241

    Google Scholar 

  67. Iruela-Arispe ML, Diglio CA, Sage EH (1991) Modulation of extracellular matrix by endothelial cells undergoing angiogenesis in vitro. Arterioscler Thromb 11:805–815

    Google Scholar 

  68. Iruela-Arispe ML, Hasselaar P, Sage H (1991) Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 64:174–186

    Google Scholar 

  69. Iruela-Arispe ML, Sage EH (1993) Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-β1. J Cell Biochem 52:414–430

    Google Scholar 

  70. Jackson D, Volpert OV, Bouck N, Linzer DIH (1994) Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266:1581–1584

    Google Scholar 

  71. Järveläinen HT, Iruela-Arispe ML, Kinsella MG, Sandell LJ, Sage EH (1992) Expression of decorin by sprouting bovine endothelial cells exhibiting angiogenesis in vitro. Exp Cell Res 203:395–401

    Google Scholar 

  72. Johnson MD, Kim HR, Chesler L, Tsao Wu G, Bouck N, Polverini PJ (1994) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160:194–202

    Google Scholar 

  73. Khouri RK, Hong SP, Deune EG, Tarpley JE, Song SZ, Serdar CM, Pierce GF (1994) De novo generation of permanent neovascularized soft tissue appendages by platelet-derived growth factor. J Clin Invest 94:1757–1763

    Google Scholar 

  74. Kim KJ, Li B, Winer J, Armanini M, Gillett NS, Phillips H, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841–844

    Article  Google Scholar 

  75. Klagsbrun M, Folkman J (1990) Angiogenesis. In: Sporn MB, Roberts AB (eds) Peptide growth factors and their receptors II. Springer, Berlin Heidelberg New York, pp 549–574

    Google Scholar 

  76. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter R (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798–1801

    Google Scholar 

  77. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong W, Pope RM, Ferrara N (1994) Vascular endothelial growth factor. a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149–4156

    Google Scholar 

  78. Koester K (1876) Endarteriitis und Arteriitis. Klin Wochenschr 13:454–455

    Google Scholar 

  79. Koos RD (1989) Potential relevance of angiogenic factors to ovarian physiology Semin Reprod Endocrinol 7:29–40

    Google Scholar 

  80. Kourembanas S, Hannan RL, Faller DV (1990) Oxygen tension regulates the expression of platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 86:670–674

    Google Scholar 

  81. Kovacs EJ, DiPietro LA (1994) Fibrogenic cytokines and connective tissue production. FASEB. J 8:854–861

    Google Scholar 

  82. Lal B, Indurti RR, Couraud PO, Goldstein GW, Laterra J (1994) Endothelial cell implantation and survival within experimental gliomas. Proc Natl Acad Sci USA 91:9695–9699

    Google Scholar 

  83. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH (1994) SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol 125:929–943

    Google Scholar 

  84. Larsen WJ (1993) Human embryology Churchill Livingstone, New York. 435–452

    Google Scholar 

  85. LeGrand EK, Burke JF, Costa DE, Kiorpes TC (1993) Dose responsive effects of PDGF-BB, PDGF-AA, EGF, and bFGF on granulation tissue in a guinea pig partial thickness skin excision model. Growth. Factors. 8:307–314

    Google Scholar 

  86. Leibovich JS, Polverini PJ, Fong TW, Harlow LA, Koch AE (1994) Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 91:4190–4194

    Google Scholar 

  87. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327–336

    Google Scholar 

  88. Loike JD, Brett L, Cao J, Ogawa S, Silverstein SC, Stern D (1994) Hypoxia induces glucose transporter expression in endothelial cells. Am J Physiol 263:C326-C233

    Google Scholar 

  89. Lüscher TF, Richard V, Tschudi M, Yang Z, Boulanger C (1990) Endothelial control of vascular tome in large and small coronary arteries. J Am Coll Cardiol 15:519–527

    Google Scholar 

  90. Lyons RM, Gentry LE, Purchio AE, Moses HL (1990) Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol 110:1361–1367

    Google Scholar 

  91. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267–9271

    Google Scholar 

  92. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77–79

    Google Scholar 

  93. Maragoudakis ME, Sarmonika M, Panoutsacopoulou M (1988) Inhibition of membrane biosynthesis prevents angiogenesis. J Pharmacol Exp Ther 244:729–733

    Google Scholar 

  94. Martins RN, Chleboun JO, Sellers P, Sleigh M, Muir J (1994) The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion. Growth Factors 10:299–306

    Google Scholar 

  95. Marx M, Perlmutter RA, Madri JA (1994) Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 93:131–139

    Google Scholar 

  96. McCaffrey TA, Falcone DJ, Brayton CF, Agarwal LA, Welt FGP, Weksler BB (1989) Transforming growth factor-β activity is potentiated by heparin via dissection of the transforming growth factor-β/α2-macroglobulin inactive complex. J Cell Biol 109:441–448

    Google Scholar 

  97. McNeil PL, Muthukrishnan L, Warder E, D'Amore PA (1989) Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109:811–822

    Google Scholar 

  98. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Lösche C, Röllmann R, Schatz H (1994) Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 92:2620–2625

    Google Scholar 

  99. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller N, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835–846

    Google Scholar 

  100. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominantnegative Flk-1 mutant. Nature 367:576–579

    Article  CAS  PubMed  Google Scholar 

  101. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, et al (1994) Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574–584

    CAS  PubMed  Google Scholar 

  102. Minchenko A, Bauer T, Salceda S, Caro J (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71:374–379

    CAS  PubMed  Google Scholar 

  103. Moghaddam A, Bicknell R (1992) Expression of platelet-derived endothelial growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31:12141–12146

    Google Scholar 

  104. Montesano R (1992) 1992 Mack Forster Award Lecture. Review. Regulation of angiogenesis in vitro. Eur J Clin Invest 22:504–515

    Google Scholar 

  105. Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, Camussi G (1994) Tumor necrosis factor α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 180:377–382

    Google Scholar 

  106. Moses MA (1993) A cartilage-derived inhibitor of neovascularization and metalloproteinases. Clin Exp Rheumatol 11 [Suppl] 8:S67-S69

    Google Scholar 

  107. Müller G, Behrens J, Nussbaumer P, Bohler P, Birchmaier W (1987) Inhibitory action of transforming growth factor β on endothelial cells. Proc Natl Acad Sci USA 84:5600–5604

    Google Scholar 

  108. Nguyen M, Strubel NA, Bischoff J (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365:267–269

    Google Scholar 

  109. Nguyen NM, Lehr JE, Pienta KJ (1993) Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Anticancer. Res 13:2143–2147

    Google Scholar 

  110. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst. 86:356–361

    Google Scholar 

  111. Nicosia RF, Villaschi S, Smith M (1994) Isolation and characterization of vasoformative endothelial cells from the rat aorta. In Vitro Cell Develop Biol 30A:394–399

    Google Scholar 

  112. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD, et al (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945–951

    CAS  PubMed  Google Scholar 

  113. O'Rahilly R, Müller F (1992) The cardiovascular and lymphatic systems. In: O'Rahilly R, Müller F (eds) Human embryology and teratology. Wiley-Liss, New York, pp 107–138

    Google Scholar 

  114. O'Reilly MA, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, J Folkman (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell 79:315–328

    Article  PubMed  Google Scholar 

  115. Oikawa T, Okayasu I, Ashino H, Morita I, Murota S, Shudo K (1993) Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. Eur J Pharmacol 249:113–116

    Google Scholar 

  116. Oliver SJ, Banquerigo ML, Brahn E (1994) Supression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and microtubule stabilizer taxol Cell Immunol 157:291–299

    Google Scholar 

  117. Page C, Rose M, Yacoub M, Pigott R (1992) Antigenic heterogeneity of vascular endothelium. Am J Pathol 141:673–683

    Google Scholar 

  118. Park JE, Chen HH, Winer J, Houck KA, Ferrara N (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 41:25646–25654

    Google Scholar 

  119. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67:519–528

    Google Scholar 

  120. Pepper MS, Ferrara N, Orci L, Montesano R (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902–906

    CAS  PubMed  Google Scholar 

  121. Pepper MS, Vassalli JD, Orci L, Montesano R (1993) Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res 204:356–363

    Google Scholar 

  122. Pepper MS, Wasi S, Ferrara N, Orci L, Montesano R (1994) In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 210:298–305

    Google Scholar 

  123. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomason A (1992) Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol 140:1375–1388

    Google Scholar 

  124. Plate KH, Breier G, Farrell CL, Risau W (1992) Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Invest 67:529–534

    Google Scholar 

  125. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848

    Google Scholar 

  126. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822–5827

    Google Scholar 

  127. Pu LQ, Sniderman AD, Brassard R, Lachapelle KJ, Graham AM, Lisbona R, Symes JF (1993) Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 88:208–215

    Google Scholar 

  128. Quyyumi AA, Diodati JG, Lakatos E, Bonow RO, Epstein SE (1993) Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study. J Am Coll Cardiol 22:635–641

    Google Scholar 

  129. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH (1992) The extracellular glycoprotein SPARC interacts with plateletderived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 89:1281–1285

    Google Scholar 

  130. Rastinejad F, Polverini PJ, Bouck NP (1989) Regulation of the activity of a novel inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345–355

    Article  Google Scholar 

  131. Ravindranath N, Little-Ihrig L, Philips HS, Ferrara N, Zeleznik A (1992) Vascular endothelial factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131:254–260

    Google Scholar 

  132. Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdin B (1993) Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invest 91:2065–2075

    Google Scholar 

  133. Reynolds LP, Killilea SD, Redmer DA (1992) Angiogenesis in the female reproductive system. FASEB J 6:886–892

    Google Scholar 

  134. Risau W (1990) Angiogenic growth factors. Prog Growth Factor Res 2:71–79

    Google Scholar 

  135. Risau W (1991) Embryonic angiogenesis factors. Pharmacol Ther 51:371–376

    Google Scholar 

  136. Risau W (1994) Angiogenesis and endothelial cell function. Arzneimittelforschung 44:416–417

    Google Scholar 

  137. Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin C (1992) Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7:261–266

    Google Scholar 

  138. Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF (1992) Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 339:23–25

    Google Scholar 

  139. Rosen EM, Zitnik RJ, Elias JA, Bhargava MM, Wines J, Goldberg ID (1993) The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis. EXS 65:301–310

    Google Scholar 

  140. Rupnik MA, Carey A, Williams SK (1988) Phenotypic diversity in cultured cerebral microvascular endothelial cells. In Vitro Cell Develop Biol 24:435–444

    Google Scholar 

  141. Sabri MN, DiSciascio G, Cowley MJ, Alpert D, Vetrovec GW (1991) Coronary collateral recruitment: functional significance and relation to rate of vessel closure. Am Heart J 121:876–880

    Google Scholar 

  142. Sakuda H, Nakashima Y, Kuriyama S, Sueishi K (1992) Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-β1. Am J Pathol 141:1507–1516

    Google Scholar 

  143. Sasayama S, Fujita M (1992) Recent insights into coronary collateral circulation. Circulation. 85:1197–1204

    Google Scholar 

  144. Sato Y, Rifkin DB (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J Cell Biol 109:309–315

    Google Scholar 

  145. Schaper W, Gorge G, Winkler B, Schaper J (1988) The collateral circulation of the heart. Prog Cardiovasc Dis 31:57–77

    Google Scholar 

  146. Schaper W, Sharma HS, Quinkler W, Markert T, Wünsch M, Scharper J (1990) Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 15:513–518

    Google Scholar 

  147. Schott RJ, Morrow LA (1993) Growth factors and angiogenesis. Cardiovasc Res 27:1155–1161

    Google Scholar 

  148. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE (1994) The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β. J Biol Chem. 269:26783–26788

    Google Scholar 

  149. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE (1994) Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem 269:26775–26782

    Google Scholar 

  150. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845

    Article  PubMed  Google Scholar 

  151. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91:2235–2243

    Google Scholar 

  152. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte R, Burdick MD, Wilke CA, Strieter RM (1994) Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179:1409–1415

    Google Scholar 

  153. Smits A, Hermansson M, Nister M, Karnushina I, Heldin CH, Westermark B, Funa K (1989) Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors 2:1–8

    Google Scholar 

  154. Soyombo AA, DiCorleto PE (1994) Stable expression of human platelet-derived growth factor B chain by bovine aortic endothelial cells. Matrix association and selective proteolytic cleavage by thrombin. J Biol Chem 269:17734–17740

    Google Scholar 

  155. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE (1988) The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. Am J Pathol 133:419–423

    Google Scholar 

  156. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, Elner S (1992) Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 141:1279–1284

    Google Scholar 

  157. Sueishi K, Kumamoto M, Sakuda H, Tanaka K (1993) Angiogenic processes in the pathogenesis of human coronary atherosclerosis. Curr Top Pathol 87:47–58

    Google Scholar 

  158. Taipale J, Koli K, Keski Oja J (1992) Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 267:25378–25384

    Google Scholar 

  159. Taipale J, Miyazono K, Heldin CH, Keski Oja J (1994) Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 124:171–181

    Google Scholar 

  160. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM (1994) Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93:662–670

    Google Scholar 

  161. Tanaka H, Sukhova GK, Libby P (1994) Interaction of the allogeneic state and hypercholesterolemia in arterial lesion foration in experimental cardiac allografts. Arterioscler Thromb 14:734–745

    Google Scholar 

  162. Teicher BA, Holden SA, Ara G, Northey D (1993) Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents. Anticancer Res 13:2101–2106

    Google Scholar 

  163. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N (1993) Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497–511

    Google Scholar 

  164. Tomoike H, Inou T, Watanabe K, Mizukami M, Kikuchi Y, Nakamura M (1983) Functional significance of collaterals during ameroid-induced coronary stenosis in conscious dogs. Circulation. 67:1001–1008

    Google Scholar 

  165. Unemori EN, Ferrara N, Bauer EA, Amento E (1992) Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153:557–562

    Google Scholar 

  166. Van Meir EG, Polverini PJ, Chazin VR, Huang SHJ, de Tribolet N, Cavenee WK (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genetics 8:171–176

    Google Scholar 

  167. Vernon RB, Angello JC, Iruela Arispe ML, Lane TF, Sage EH (1992) Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro. Lab Invest 66:536–547

    Google Scholar 

  168. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH (1992) Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 202:1–8

    Google Scholar 

  169. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S (1992) Tumor angiogenesis in prostatic carcinoma with and without bone metastasis; a morphometric study. Am J Pathol 168:257–262

    Google Scholar 

  170. Weidner N (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 10:302–313

    Google Scholar 

  171. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    Google Scholar 

  172. Weindel K, Marmé D, Weich HA (1992) AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 183:1167–1174

    Google Scholar 

  173. Weinstat-Saslow D, Steeg PS (1994) Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8:401–407

    Google Scholar 

  174. White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A (1991) Treatment of childhood angiomatous diseases with recombinant interferon-2a. J Ped 118:59–66

    CAS  PubMed  Google Scholar 

  175. Wolfe MM, Bynum TE, Parsons WG, Malone KM, Szabo S, Folkman J (1994) Safety and efficacy of an angiogenic peptide, basic fibroblast growth factor (bFGF) in the treatment of gastroduodenal ulcers: a preliminary report. Gastroenterology 106:A212

    Google Scholar 

  176. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, et al (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401–1403

    Google Scholar 

  177. Zhang Y, Cliff WJ, Schoefl GI, Higgins G (1993) Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 143:164–172

    Google Scholar 

  178. Ziche M, Morbidelli L, Alessandri G, Gullino P (1992) Angiogenesis can be stimulated or repressed in vivo by a change in GM3∶GD3 ganglioside ratio. Lab Invest 67:711–715

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Research and Internal Medicine, University Hospitals, CH-4031, Basel, Switzerland

    E. J. Battegay

Authors
  1. E. J. Battegay
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Battegay, E.J. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73, 333–346 (1995). https://doi.org/10.1007/BF00192885

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00192885

Key words

Search

Navigation